Literature DB >> 19183252

Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.

Toni L Richards1, Nancy R Zahniser.   

Abstract

The dopamine transporter (DAT) substrates dopamine, d-amphetamine (AMPH), and methamphetamine are known to rapidly and transiently reduce DAT activity and/or surface expression in dorsal striatum and heterologous expression systems. We sought to determine if similar substrate-induced regulation of DATs occurs in rat nucleus accumbens. In dorsal striatum synaptosomes, brief (15-min) in vitro substrate pre-exposure markedly decreased maximal [(3)H]dopamine uptake velocity whereas identical substrate pre-exposure in nucleus accumbens synaptosomes produced a smaller, non-significant reduction. However, 45 min after systemic AMPH administration, maximal ex vivo [(3)H]dopamine uptake velocity was significantly reduced in both brain regions. Protein kinase C inhibition blocked AMPH's down-regulation of DAT activity. DAT synaptosomal surface expression was not modified following either the brief in vitro or in vivo AMPH pre-exposure but was reduced after a longer (1-h) in vitro pre-exposure in both brain regions. Together, our findings suggest that relatively brief substrate exposure results in greater down-regulation of DAT activity in dorsal striatum than in nucleus accumbens. Moreover, exposure to AMPH appears to regulate striatal DATs in a biphasic manner, with an initial protein kinase C-dependent decrease in DAT-mediated uptake velocity and then, with longer exposure, a reduction in DAT surface expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183252      PMCID: PMC2885765          DOI: 10.1111/j.1471-4159.2009.05910.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

Review 1.  Biogenic amine transporters: regulation in flux.

Authors:  R D Blakely; A L Bauman
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

Review 2.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

Review 3.  Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.

Authors:  Joshua M Gulley; Nancy R Zahniser
Journal:  Eur J Pharmacol       Date:  2003-10-31       Impact factor: 4.432

4.  Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.

Authors:  C Saunders; J V Ferrer; L Shi; J Chen; G Merrill; M E Lamb; L M Leeb-Lundberg; L Carvelli; J A Javitch; A Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.

Authors:  G M Daniels; S G Amara
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

Authors:  James D Foster; Benchaporn Pananusorn; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

7.  Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo.

Authors:  Joshua M Gulley; Suzanne Doolen; Nancy R Zahniser
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

8.  Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations.

Authors:  Limen Chi; Maarten E A Reith
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

Review 9.  Dynamic regulation of the dopamine transporter.

Authors:  Ole V Mortensen; Susan G Amara
Journal:  Eur J Pharmacol       Date:  2003-10-31       Impact factor: 4.432

10.  N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.

Authors:  Habibeh Khoshbouei; Namita Sen; Bipasha Guptaroy; L 'Aurelle Johnson; David Lund; Margaret E Gnegy; Aurelio Galli; Jonathan A Javitch
Journal:  PLoS Biol       Date:  2004-03-16       Impact factor: 8.029

View more
  26 in total

1.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

2.  Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons.

Authors:  Anjali Rao; Toni L Richards; Diana Simmons; Nancy R Zahniser; Alexander Sorkin
Journal:  FASEB J       Date:  2012-01-20       Impact factor: 5.191

3.  Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

Authors:  Christopher L German; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

4.  Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain.

Authors:  Kymry T Jones; Catherine Woods; Juan Zhen; Tamara Antonio; Kenneth D Carr; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-01-31       Impact factor: 5.372

5.  A Single Amphetamine Infusion Reverses Deficits in Dopamine Nerve-Terminal Function Caused by a History of Cocaine Self-Administration.

Authors:  Mark J Ferris; Erin S Calipari; Jamie H Rose; Cody A Siciliano; Haiguo Sun; Rong Chen; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2015-02-18       Impact factor: 7.853

Review 6.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

7.  Low and high cocaine locomotor responding male Sprague-Dawley rats differ in rapid cocaine-induced regulation of striatal dopamine transporter function.

Authors:  Bruce H Mandt; Nancy R Zahniser
Journal:  Neuropharmacology       Date:  2009-12-04       Impact factor: 5.250

8.  A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity.

Authors:  Mia Apuschkin; Sara Stilling; Troels Rahbek-Clemmensen; Gunnar Sørensen; Guillaume Fortin; Freja Herborg Hansen; Jacob Eriksen; Louis-Eric Trudeau; Kristoffer Egerod; Ulrik Gether; Mattias Rickhag
Journal:  Eur J Neurosci       Date:  2015-09-30       Impact factor: 3.386

9.  Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent, regionally selective bimodal effects on striatal dopamine kinetics in vivo.

Authors:  Rashed Harun; Kristin M Hare; Elizabeth M Brough; Miranda J Munoz; Christine M Grassi; Gonzalo E Torres; Anthony A Grace; Amy K Wagner
Journal:  J Neurochem       Date:  2016-01-13       Impact factor: 5.372

10.  Preserved dopaminergic homeostasis and dopamine-related behaviour in hemizygous TH-Cre mice.

Authors:  Annika H Runegaard; Kathrine L Jensen; Ciarán M Fitzpatrick; Ditte Dencker; Pia Weikop; Ulrik Gether; Mattias Rickhag
Journal:  Eur J Neurosci       Date:  2016-08-22       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.